Minor clone provides a reservoir for relapse in multiple myeloma-Reference-Cited by-同舟云学术

Minor clone provides a reservoir for relapse in multiple myeloma

Published:2012-08-09 Issue:2 Volume:27 Page:473-481
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Magrangeas F,Avet-Loiseau H,Gouraud W,Lodé L,Decaux O,Godmer P,Garderet L,Voillat L,Facon T,Stoppa A M,Marit G,Hulin C,Casassus P,Tiab M,Voog E,Randriamalala E,Anderson K C,Moreau P,Munshi N C,Minvielle S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012226.pdf

Reference33 articles.

1. Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, van Rhee F et al. Thalidomide and hematopoietic-cell transplantation for multiple myeloma. N Engl J Med 2006; 354: 1021–1030.

2. Facon T, Mary JY, Hulin C, Benboubker L, Attal M, Pegourie B et al. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. Lancet 2007; 370: 1209–1218.

3. San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M et al. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med 2008; 359: 906–917.

4. Harousseau JL, Attal M, Avet-Loiseau H, Marit G, Caillot D, Mohty M et al. Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial. J Clin Oncol 2010; 28: 4621–4629.

5. Rajkumar SV, Jacobus S, Callander NS, Fonseca R, Vesole DH, Williams ME et al. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. Lancet Oncol 2010; 11: 29–37.

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting GPRC5D in multiple myeloma;Expert Review of Anticancer Therapy;2024-04-16

2. Chromosomal defects in multiple myeloma;Blood Reviews;2024-03

3. Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma;Scientific Reports;2023-11-08

4. Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial Subanalysis;Clinical Lymphoma Myeloma and Leukemia;2023-09

5. Putting the best foot forward when treating newly diagnosed multiple myeloma;Internal Medicine Journal;2023-03